Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any microphthalmia with linear skin defects syndrome in which the cause of the disease is a mutation in the HCCS gene.
Features include always present findings: Asymmetric, linear skin defects; and very common findings: Microphthalmia. 36 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 5 | Junctional ectopic tachycardia, Histiocytoid cardiomyopathy, Arrhythmia |
Brain and nerves | 4 | Seizure, Hydrocephalus, Intellectual disability |
Eyes | 2 | Pigmentary retinopathy, Cataract |
Head and neck | 2 | Microcephaly, Cleft palate |
Ears | 1 | Hearing loss (hearing impairment) |
Growth and development | 1 | Short stature |
Pregnancy and birth | 1 | Congenital diaphragmatic hernia |
Skin | 1 | Asymmetric, linear skin defects |
Microphthalmia with linear skin defects (MLS) syndrome is characterized by unilateral or bilateral microphthalmia or anophthalmia and/or jagged skin defects on the face and neck . MLS syndrome is usually lethal in males [, , , , , , , , , ]. Phenotypic variability. Inter- and intrafamilial phenotypic variability has been described. The manifestations differ among affected individuals and, although most display the classic phenotype of MLS syndrome, many have only a subset of characteristic features: some show the characteristic skin defects without ocular abnormalities, whereas others have eye abnormalities without skin defects . For example, a female with a normal phenotype except for typical MLS syndrome skin defects had an affected female fetus with anencephaly.
Eye finding...
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"
HCCS encodes holocytochrome c synthase (268 aa). Lyase that catalyzes the covalent linking of the heme group to the cytochrome C apoprotein to produce the mature functional cytochrome Highest expression in Cells EBV-transformed lymphocytes (31.5 TPM) and Cells Cultured fibroblasts (30.6 TPM).
Linear skin defects with multiple congenital anomalies 1 is associated with mutations in the HCCS gene on chromosome X.
The HCCS protein participates in HCCS inserts heme into cytochrome c and CCS transfers Cu to SOD1 and oxidizes cysteine residues in SOD1 pathways.
HCCS is classified as a druggable target (Enzyme category) with score 0.0.
Microphthalmia with linear skin defects (MLS) syndrome should be suspected in females with one or both major criteria especially in the presence of a family history consistent with X-linked inheritance with male lethality (see , , and ). Almost all individuals with MLS syndrome are female; however, a few affected males, typically with an XX karyotype, have been reported.
Major Criteria
Microphthalmia and/or anophthalmia
Reported in 81% of affected individuals
Can be unilateral or bilateral
Linear skin defects
Reported in 75% of affected individuals
Present at birth
Usually involve the face and neck , although the scalp and occasionally the upper trunk may be involved
Heal with age, leaving minimal residual scarring
The clinical signs observed in ML...
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"
Table 2. Disorders to Consider in the Differential Diagnosis of MLS Syndrome
Disorder | Gene(s) | MOI | Clinical Features |
|---|---|---|---|
PORCN | XL | Distinctive skin findings (dermal hypoplasia); Ophthalmologic manifestations | — |
In focal dermal hypoplasia:limb skeletal malformations Incontinentia pigmenti (IP) | IKBKG(NEMO) | XL |
Genetic testing for HCCS is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for linear skin defects with multiple congenital anomalies 1. The disease remains an area of unmet medical need.
To establish the extent of disease and needs in an individual diagnosed with microphthalmia with linear skin lesions (MLS) syndrome, the following evaluations (if not performed as part of the evaluation that led to the diagnosis) are recommended:
Ophthalmologic examination
Dermatologic evaluation for skin lesions
Brain MRI for corpus callosum dysgenesis and other neurologic abnormalities
Developmental assessment, with further evaluation if significant delays are identified
Cardiac evaluation
Hearing evaluation, as hearing loss is observed in 8% of cases
Consideration of abdominal MRI and standard protocols for management of diaphragmatic hernia
Consultation with a clinical geneticist and/or genetic counselor
The following are appropriate:
Under the guidance of an oculoplastics specialist, use of a prosthesis in severe microphthalmia and anophthalmia
Regular care by a dermatologist for individuals with significant skin lesions
Referral to a pediatric neurologist for evaluation and treatment if microcephaly, seizures, and/or other neurologic abnormalities are present
Appropriate developmental therapies and special education as indicated for developmental delay and intellectual disability
Standard care for cardiac concerns and other malformations, when present
Monitoring and follow up with ophthalmologist, dermatologist, pediatric neurologist, and other professionals as needed is appropriate. Affected indi...
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"
View trials for linear skin defects with multiple congenital anomalies 1
Monitoring and follow up with ophthalmologist, dermatologist, pediatric neurologist, and other professionals as needed is appropriate. Affected individuals with cardiac concerns should have regular complete evaluation at intervals determined by the cardiologist.
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"
Phenotype severity distribution: 1 always present feature, 1 very common feature, 1 common feature.
No clinical trials have been registered for linear skin defects with multiple congenital anomalies 1.
4 publications have been identified in PubMed for linear skin defects with multiple congenital anomalies 1. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (25%), and Basic Science / Preclinical (25%).
D'Alessio AM (2026). [PMID: 42014911](https://pubmed.ncbi.nlm.nih.gov/42014911/). *Eur J Hum Genet*. [Review / Meta-Analysis]
Lucas SAM (2025). [PMID: 40330260](https://pubmed.ncbi.nlm.nih.gov/40330260/). *Clinical case reports*. [Case Report / Case Series]
Sahajpal NS (2025). [PMID: 40107724](https://pubmed.ncbi.nlm.nih.gov/40107724/). *Genome research*. [Basic Science / Preclinical]
Mehawej C (2024). [PMID: 39062680](https://pubmed.ncbi.nlm.nih.gov/39062680/). *Genes*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 6:57 PM UTC
Online Mendelian Inheritance in Man
Skin lesions; Ocular abnormalities (present in 35% of those w/IP diagnosis)
Verrucous lesions Oculocerebro-cutaneous syndrome (OCCS)(OMIM 164180) | ? | ? | Focal skin defects; Anophthalmia / microphthalmia |
Aicardi syndrome | ? | XL | Microphthalmia; Pigmentary lesions of the skin |
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"